• Profile
Close

Effect of oral capsule–vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: A randomized clinical trial

JAMA Dec 04, 2017

Kao D, et al. - The authors investigated if fecal microbiota transplantation (FMT) by oral capsule was noninferior to colonoscopy delivery in efficacy, in preventing recurrent Clostridium difficile infection (RCDI). The findings revealed that FMT via oral capsules was not inferior to delivery by colonoscopy for preventing recurrent infection over 12 weeks, among adults with RCDI. It was observed that treatment with oral capsules could be an effective approach for treating RCDI.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay